Patient characteristics
| Factors at ICU admission | |
| Age years | 62 (53–71) |
| Alcohol abuse | 31 (24.8) |
| Performance status | |
| 0 | 32 (25.6) |
| 1 | 47 (37.6) |
| 2 | 35 (28) |
| 3 | 10 (8) |
| 4 | 1 (0.8) |
| Comorbidities | |
| COPD | 38 (30.4) |
| Cardiovascular disease | 62 (49.6) |
| Anticoagulant treatment | 19 (15.2) |
| Antiplatelet treatment | 32 (25.6) |
| Cancer characteristics | |
| Subtype | |
| Squamous cell carcinoma | 65 (52) |
| Adenocarcinoma | 31 (24.8) |
| Other | 29 (23.2) |
| Cancer stage# | |
| I–IIIA | 37 (29.6) |
| IIIB–IV | 87 (69.6) |
| Necrosis or cavitation | 26 (20.8) |
| Central location¶ | 91 (72.8) |
| Anticancer treatments prior to current hospital stay | |
| None | 73 (58.4) |
| Surgery | 1 (0.8) |
| Chest radiation therapy | 13 (10.4) |
| Chemotherapy | 47 (37.6) |
| Cancer status | |
| Controlled | 11 (8.8) |
| Progressive | 31 (24.8) |
| Unknown | 83 (66.4) |
| Haemoptysis characteristics | |
| Cumulative volume at admission+ mL | 200 (100–300) |
| Haemoglobin g·dL−1 | 10.6 (9.1–12) |
| Main therapeutics in ICU | |
| Mechanical ventilation | 38 (30.4) |
| Vasopressors | 21 (16.8) |
| Transfusion | 29 (23.2) |
| Haemoptysis therapeutics | |
| Medical treatment | 20 (16) |
| Bronchial arteriography | 102 (81.6) |
| Embolisation | 89 (71.2) |
| Surgery | 18 (14.4) |
| Survival | |
| ICU | 104 (83.2) |
| Hospital | 86 (68.8) |
| 1 year§ | 38 (30.4) |
| Cancer treatment after ICU discharge | 60 (48) |
Data are presented as median (interquartile range) or n (%). N=125. ICU: intensive care unit; COPD: chronic obstructive pulmonary disease. #: in one stage III nonsmall cell lung cancer patient the A or B staging could not be determined; ¶: in three patients the location could not be determined; +: in 14 patients requiring mechanical ventilation the amount of bleeding could be not evaluated; §: missing data for two patients.